VEGFA and oligodendroglioma: Four of six patients plotted in Figure 1 (one oligodendroglioma, patient (P) 1; one breast cancer, P3; one melanoma, P4; one lung cancer P5) were evaluable for the effects of primary intrathecal or systemic chemotherapy with or without radiotherapy on CSF VEGF.